December 18, 2025

When Immigration Fear Delays Care

Health systems report increased no-shows and unmet needs as immigration operations expand.

KFF Health News

December 18, 2025

New Approach Methodologies: Why the Future of Drug Development Must Be Human

NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?

The Medicine Maker

December 18, 2025

Industry Insights: Let’s Automate the Future

Luca Quagliata, Vice President and Global Head of Medical Affairs at Thermo Fisher Scientific, shares his insights into the precision medicine priorities for the diagnostics industry

The Pathologist

December 17, 2025

Bridging the Digital Divide: How Collaboration and Standardization Are Shaping the Future of Biotech

The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.

The Medicine Maker

December 17, 2025

Lung Cancer Screening Follow-up Shows Gaps

Investigators highlight disparities in diagnostic follow-up intensity after abnormal lung cancer screening findings across Lung Imaging Reporting and Data System categories using a national analysis of registry-linked Medicare data.

Conexiant

December 17, 2025

Could This Be the First Definitive Test for ME/CFS?

UK researchers identify distinct 3D genomic markers that could help diagnose ME/CFS in weeks – not years

The Pathologist

December 17, 2025

What Your Microbiome Says About Your Heart

Metagenome-assembled genomes reveal species and pathways tied to coronary artery disease risk

The Pathologist

December 17, 2025

Hidden Drugs Revealed By Tandem Mass Spectrometry 

By matching mass spectra to curated references, the GNPS Drug Library links patient samples to over 2,000 drugs, metabolites, and environmental chemicals

The Analytical Scientist

December 17, 2025

Promising Data For Off-the-Shelf Gene-edited Cell Therapy

New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia

The Medicine Maker